XTL Biopharmaceuticals Ltd.

Report Publication Announcement • Aug 15, 2006

_________

C004��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD5286Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996352Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: rcohen@xtlbio.comDate of transmission: 15/08/2006              Time of broadcast: 10:09 09:51:07

Reference: 2006-02-075340

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate report on other matterDon't use this form if there is more adequate one

XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2006
Attached file June302006_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 04/06/2006
- - -
Name of the Signatory: : Kessler Zev Aryeh , , Position of Signatory in the reporting corporation: Director of Finance
Sapir Telephone: 08-9304404 , Facsimile: 08-9300659 , E-mail: bkessler@xtlbio.com